Sun Pharma hit with another fire at an Indian plant

By Staff Reporter

- Last updated on GMT


Related tags: Pharmaceutical drug, Pharmacology, Sun pharma

Sun Pharma says there was no direct loss of production at its Gujarat active pharmaceutical ingredient (API) facility following a fire last week.

According to Indian drugmaker Sun Pharma, a fire broke out within the solvent storage area at its API facility in Ankleshwar, Gujarat during the early hours of February 4.

The news was broken by Indian media (footage taken from the scene by news outlet Connect Gujarat TV can be seen below) and confirmed several days later by Sun Pharma in a filing with the Bombay Stock Exchange.

“The fire was put off by the site firefighting team with support from the DMPC fire tenders. There were no injuries during this incident and the situation is under control. There was no direct loss of production because of this incident,”​ the firm said.

“A detailed investigation is under progress.”

The firm added as this is not a material event under Regulation 30 of the Listing Regulations it has no bearing on the company’s performance.

No further details were divulged when in-Pharmatechnologist contacted the firm.

The facility makes a number of APIs and pharma intermediates and has ISO 9002 and WHO GMP accreditation.

This is the second fire to hit Sun Pharma’s manufacturing network within 14 months. A fire broke out at the company’s Ahmednagar factory on December 28, 2016​ during excavation work, killing two employees.

Related news

Show more

Related products

show more

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...


NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers

Follow us

Featured Events

View more


View more